Expression of cathepsin B and microvascular density increases with higher grade of astrocytomas.
Samples were taken from supratentorial gliomas border and normal brain autopsy which were divided into four groups, these including eight cases normal brain tissues, 30 cases of astrocytomas, 25 cases of anaplastic astrocytomas and 22 cases of glioblastomas. Cathepin B (CB) expression and microvessel density (MVD) were determined with immunohistochemical studies. Staining results of CB was scored according to the percentage of positive cells, graded as negative (-), weak (+), moderate (++), and strong (+ + +). MVD was analyzed by Weidner's revised technique. CB positive staining was negative in eight cases of normal brain tissue. Only 9 out of 30 cases of astrocytomas showed a low percentage of positive cells that were stained in a light, diffuse cytoplasmic pattern (score +). Twenty-two out of 35 cases of anaplastic astrocytomas showed positive light, granular staining pattern, it including five samples (score +), and 17 samples (score + +). In contrast, all 22 cases of glioblastomas were stained all, and it was present in a course, granular staining pattern with an intensity of score (+ +) of two sample, and score (+ + +) of 20 samples. Positive staining tumor cells were found in extracellular matrix (ECM), basement membrane (BM), and the endothelial cells of blood vessels were also positive stained. Along with elevating glioma grade, CB expression and MVD value were both increased. Therefore, it showed MVD value was positive correlated with expression of CB. It highly suggested that CB and angiogenesis plays an important role in glioma progression.
Wang
Maode
M
Department of Neurosurgery, The First Hospital, Xi'an Jiaotong University, 710061, No. 1 Jiankang Road, Xi'an, China. maodewang@yahoo.com.cn
Tang
Jianjian
J
Liu
Shouxun
S
Yoshida
Daizo
D
Teramoto
Akira
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000098:blood supply* / Q000201:enzymology* / Q000473:pathology; D002401:Cathepsin B / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000473:pathology; D005260:Female; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D005909:Glioblastoma / Q000098:blood supply / Q000201:enzymology / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D012720:Severity of Illness Index; D015173:Supratentorial Neoplasms / Q000098:blood supply* / Q000201:enzymology* / Q000473:pathology
D002401:Cathepsin B
Biol Chem Hoppe Seyler. 1992 Jul;373(7):611-22
1515091
Biochem J. 1992 Feb 15;282 ( Pt 1):273-8
1540143
Anat Rec. 1998 Oct;252(2):281-9
9776083
Oncogene. 2002 Dec 12;21(57):8705-12
12483523
J Neurooncol. 2002 May;58(1):21-32
12160137
Hum Pathol. 1999 Jun;30(6):680-6
10374777
Br J Cancer. 1999 Oct;81(3):510-9
10507778
Eur J Biochem. 2000 Jul;267(13):4165-70
10866820
FEBS Lett. 1999 Jul 23;455(3):286-90
10437790
Cancer Gene Ther. 2003 Feb;10(2):141-51
12536203
Am J Pathol. 1990 Nov;137(5):1121-42
1700617
Neurosurgery. 2002 Mar;50(3):578-86; discussion 586-8
11841727
Biochim Biophys Acta. 1993 Jul 28;1178(1):55-62
8329457
J Neuropathol Exp Neurol. 1999 Oct;58(10):1029-40
10515226
Clin Exp Metastasis. 1992 May;10(3):145-55
1582084
Neurosurgery. 2003 Jan;52(1):187-96; discussion 196-7
12493117
J Pathol. 1997 Jun;182(2):205-10
9274532
Cancer Res. 1989 Sep 1;49(17):4870-5
2758418
Cell. 1991 Jan 25;64(2):327-36
1703045
J Biol Chem. 2000 Apr 28;275(17):12806-12
10777578
Surg Today. 2001;31(5):385-9
11381499
Biol Chem. 1998 Feb;379(2):125-30
9524063
Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):483-94
10571410
Am J Pathol. 1998 Aug;153(2):429-37
9708803
Oncogene. 2001 Jun 21;20(28):3665-73
11439329
Cancer. 1996 Jan 15;77(2):362-72
8625246
Int J Oncol. 2001 Sep;19(3):519-24
11494030
Brain Pathol. 1994 Apr;4(2):157-66
7520326
J Neurosurg. 1995 Aug;83(2):285-90
7542317
N Engl J Med. 1991 Jan 3;324(1):1-8
1701519
J Clin Oncol. 1998 Mar;16(3):1013-21
9508185
Anticancer Res. 1997 Nov-Dec;17(6D):4747-53
9494601